Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Summary Of Proceeding Of The Forty Seventh Annual General Meeting

We wish to inform you that the 47th Annual General Meeting of the Members of the Company was held on Tuesday, September 29, 2020 at 2 p.m. through Video Conferencing ('VC')/ other Audio-Visual Means ('OAVM') for transacting the business mentioned in the Notice convening the AGM dated August 29, 2020. Pursuant to Regulation 30 read with Para A of Part A in schedule III of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we are enclosing a summary of the proceedings of the Company's Forty Seventh Annual General Meeting.
30-09-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Shareholder Meeting / Postal Ballot-Outcome of AGM

We wish to inform you that the 47th Annual General Meeting of the Members of the Company was held on Tuesday, September 29, 2020 at 2 p.m. through Video Conferencing ('VC')/ other Audio-Visual Means ('OAVM') for transacting the business mentioned in the Notice convening the AGM dated August 29, 2020. Pursuant to Regulation 30 read with Para A of Part A in schedule III of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we are enclosing a summary of the proceedings of the Company's Forty Seventh Annual General Meeting. We request you to disseminate the above information on your website.
30-09-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Reg. 34 (1) Annual Report

This is to inform you that the 47th Annual General Meeting of the Members of the Company is scheduled to be held on Tuesday, September 29, 2020 at 02.00 pm through Video Conferencing ("VC") / Other Audio Visual Means ("OAVM"), in compliance with the General Circular No. 14/2020 dated April 8, 2020, 17 /2020 dated April 13, 2020 and 20/2020 dated May 5, 2020 issued by the Ministry of Corporate Affairs (''MCA circulars''), and other applicable provisions of the Companies Act, 2013 and SEBI Circular no. SEBI/HO/CFD/CMDl/CIR/P/2020/79 dated May 12, 2020, to transact the businesses as set forth in the Notice of AGM. Pursuant to Regulation 30 and 34 (1) of Listing Regulations, we enclose herewith the Annual Report of the Company for the Financial Year 2019-20, including the Notice of the 47th Annual General Meeting scheduled to be held on September 29, 2020.
05-09-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 47(1) of SEBI (Listing Obligations and Disclosure Requirements), 2015, we enclose herewith clipping of the public notice of 47th Annual General Meeting scheduled to be held on Tuesday, September 29, 2020 as published on 'Business Standard' in English language and in Mumbai Lakshyadeep in Marathi language. Kindly take the same on record.
04-09-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Change in Directorate

In terms of the above referred regulations read with its Part A of Schedule III, we wish to inform you that the Board of Directors of the Company at its meeting held on August 29, 2020 has approved the appointment of Mr. Nikunj Mange and Mr. Yash Bhanushali as an Additional Executive Director of the Company with effect from August 29, 2020.
29-08-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Intimation Of Day, Date And Time Of Annual General Meeting

We wish to inform you that the 47th Annual General Meeting (AGM) of the Company will be held on Tuesday, 29th September, 2020 at 02: 00 PM through Video Conferencing ('VC')/Other Audio Visual Means ('OAVM') and it is permitted by the Ministry of Corporate Affairs through its General Circulars Nos. 14/2020, 17/2020 and 20/2020 issued in April and May 2020 respectively read with the Securities and Exchange Board of India Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/79 dated May 12, 2020. The annual report of the Company for the financial year 2019-20, which inter-alia, contains the Notice of 47th AGM giving the instructions for attending the meeting through VC/OAVM and for e-voting, will be sent only in electronic mode to all those members who have registered their e-mail addresses with their respective Depository Participants or the Company or its Registrar and Transfer Agents.
29-08-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Intimation Of Book Closure Pursuant To Regulations 42 Of The Securities & Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015.

With reference to the captioned subject, we wish to inform you that the register of members and share transfer book of the company will be closed from Wednesday, September 23, 2020 to Tuesday, September 29, 2020, (both days inclusive) for the 47th Annual General Meeting.
29-08-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Intimation To Stock Exchanges Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")

In terms of SEBI Listing Regulations, we wish to inform you that the Board of Directors of the Company at its meeting held on August 29, 2020 has approved following: 1. In relation to the proposed fund raising by preferential allotment of equity shares by the Aspira Pathlab & Diagnostics Limited (the "Company'). In furtherance to our letter dated August 24, 2020, with respect to the issuance of Equity Shares on a preferential basis, we wish to inform you that the board of directors of the Company (the "Board") at its meeting held on August 29, 2020, subject to the approval of the shareholders of the Company, has approved the issue and allotment of 10,00,000 (Ten Lakhs) Equity Shares of face value of INR 10/- each, at an issue price Rs. 30 (Rupees Thirty) including premium of Rs. 20 (Rupees Twenty) to strategic investors not forming part of promoter or promoter group, on a preferential basis, on terms and conditions as approved by the Board.
29-08-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Raising of Funds

In terms of SEBI Listing Regulations, we wish to inform you that the Board of Directors of the Company at its meeting held on August 29, 2020 has approved following: 1. In relation to the proposed fund raising by preferential allotment of equity shares by the Aspira Pathlab & Diagnostics Limited (the "Company'). In furtherance to our letter dated August 24, 2020, with respect to the issuance of Equity Shares on a preferential basis, we wish to inform you that the board of directors of the Company (the "Board") at its meeting held on August 29, 2020, subject to the approval of the shareholders of the Company, has approved the issue and allotment of 10,00,000 (Ten Lakhs) Equity Shares of face value of INR 10/- each, at an issue price Rs. 30 (Rupees Thirty) including premium of Rs. 20 (Rupees Twenty) to strategic investors not forming part of promoter or promoter group, on a preferential basis, on terms and conditions as approved by the Board.
29-08-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2020 ,inter alia, to consider and approve We would like to bring to your notice that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, August 29, 2020. At the said meeting, inter-alia, the following proposal are being placed for consideration/review, for obtaining approval from the shareholders at the ensuing Annual General Meeting of the Company: Raising of funds by way of issue of equity shares through preferential issue, subject to such approval as may be required. This intimation is submitted pursuant to and in terms of Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We would like to bring to your notice that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, August 29, 2020. At the said meeting, inter-alia, the following proposal are being placed for consideration/review, for obtaining approval from the shareholders at the ensuing Annual General Meeting of the Company: Raising of funds by way of issue of equity shares through preferential issue, subject to such approval as may be required. This intimation is submitted pursuant to and in terms of Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
24-08-2020
Next Page
Close

Let's Open Free Demat Account